The expression of B-cell antigens, including CD19, CD79a, and PAX5, in AML with t(8;21)(q22;q22) RUNX1::RUNX1T1 is established in the literature [10,11]. This evidence concerns the gene RUNX1 and acute myeloid leukemia.